OKLAHOMA CITY – OU Medicine and its academic partner, the University of Oklahoma Health Sciences Center, recently received $100,000 from CompSource Mutual Insurance Company to assist healthcare providers on the front line of treating patients during the COVID-19 pandemic.OKLAHOMA CITY – OU Medicine and its academic partner, the University of Oklahoma Health Sciences Center, recently received $100,000 from CompSource Mutual Insurance Company to assist healthcare providers on the front line of treating patients during the COVID-19 pandemic.OKLAHOMA CITY – OU Medicine and its academic partner, the University of Oklahoma Health Sciences Center, recently received $100,000 from CompSource Mutual Insurance Company to assist healthcare providers on the front line of treating patients during the COVID-19 pandemic.

Both adults and children with diabetes that is not well controlled may face a higher risk of complications if they contract COVID-19. Healthcare leaders at Harold Hamm Diabetes Center at OU Medicine are providing awareness and guidance during the ongoing spread of the virus.

In preparation for an anticipated surge of patients with COVID-19 requiring hospitalization, OU Medicine has established a four-phase surge plan to admit and treat hundreds of critically ill patients beyond normal hospital capacity.

OU Medicine approved for clinical trial of COVID-19 therapy for hardest hit patients.